This review is a summary of a recent speaker event on symdeko (tezacaftor-ivacaftor): A new cystic fibrosis transmembrane conductance regulator modulator.
The presentation was given by Professor Jennifer Taylor-Cousar, Professor of Adult and Paediatric Pulmonary Medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services and oversees the care of children with pulmonary disease and adults with cystic fibrosis.
Please login below to download this issue (PDF)